BSECompany Update20h ago · 30 Oct 2026, 07:50 pm

Incorporation of a Wholly Owned Subsidiary in the United States of America (USA).

Vimta Labs Ltd-$ · 524394

✦ AI SummaryM&A

Vimta Labs Ltd has incorporated a wholly owned subsidiary, Vimta Labs LLC, in the United States of America. The subsidiary will support the parent company's core business lines, including preclinical studies, clinical trials, and analytical testing for pharmaceutical and biologics CRAD services.

Analysis Scores

Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Vimta Labs Ltd-$ - 524394 - Announcement under Regulation 30 (LODR)-Acquisition

Attachments (1)

📄

f5ffc74c-9542-4713-a743-1af69c0db80c.pdf

pdf

Download →
View document text
Vimta Labs Limited 'Jima Registered Office 142, lDA.Phase II, Cherlapally Hyderabad-500 051 ,Telangana, India T: +91 40 2726 4141 F : +91 40 2726 3657 Driven by Quality. Inspired by Science. VLL\SE\053\2026 27 Date: 30.10.2026 Dear Sir Madam, Sub Incorporation of a Wholly Owned Subsidiary. Ref Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Further to our earlier intimation dated 06th May 2026 and Pursuant to Regulations 30 read with Schedule III Para A of Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Listing Regulations"), we wish to inform you that, the Board of Directors of the Company at its meeting held today 30t1. October 2026, has noted the incorporation of a Wholly Owned Subsidiary in the United States of America (USA). Further, the details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended and Schedule III thereof read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3 62 2026 issued on January 30, 2026, are enclosed is annexed herewith as Annexure-A. This is for your information and records. Thanking you, For VIMTA LABS LIMITED Sujani Vasireddi Company Secretary & Compliance Officer End: as above. Life Sciences Campus, # 5, Neovantage Science & Technology Park, Genome Valley, Shamirpet, Medchal-Malkajgiri District. Hyderabad -500 101, Telangana, India. T: +91 4067404040 E: mdoffice@vimta.com URL : www.virnta.com CIN : L241101G1990PLC011917 Name of the entity, date & country of Name of the Entity: Vimta Labs LLC incorporation, etc.; Country of Incorporation: United States of America (USA) Date of Incorporation: 24-09 -2026 Name of holding company of the Vimta Labs LLC has been incorporated as a incorporated company and relation with Wholly Owned Subsidiary of Vimta Labs the listed entity; Limited. Industry to which the entity being Contract Research Organization. Vimta LLC is a newly incorporated Wholly Owned Subsidiary of Vimta Labs Limited, a leading contract research and testing organization (CRO/CRTO). The Subsidiary will support the parent company's core business lines, which include, Preclinical Studies, Clinical Trails & Analytical testing for the Pharmaceutical & growing Biologics CRAD Serviecs. Brief details of any governmental or Not Applicable (The Incorporation of regulatory approvals required for the wholly owned subsidiary Company will be incoreoration; done as per the applicable laws in the USA) .4 100% subscription to initial paid-up capital is in Cash. Further, the investment will be in one or more tranches as per business requirement. 7 Cost of Investment; Total investment amount: USD: 8,500 Percentage of control by the listed Vimta Labs Limited holds 100% of the entity shareholding in Vimta Labs LLC, making it a Wholly Owned Subsidiary of the Comvanv.